Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine

被引:61
作者
Maslanka, SE
Tappero, JW
Plikaytis, BD
Brumberg, RS
Dykes, JK
Gheesling, LL
Donaldson, KBJ
Schuchat, A
Pullman, J
Jones, M
Bushmaker, J
Carlone, GM
机构
[1] Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] St James Community Hosp, Butte, MT 59701 USA
关键词
D O I
10.1128/IAI.66.6.2453-2459.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neisseria meningitidis serogroup C bactericidal titers and class-specific enzyme-linked immunosorbent assay (ELISA) antibody concentrations were measured in sera from 173 children (1 to 5 years old) before and 6 weeks and 7 months following vaccination with a quadrivalent (A/C/Y/W-135) polysaccharide vaccine. The immune responses of the children were compared with those of 40 adults 6 weeks postvaccination. Both bactericidal titers and ELISA antibody concentrations were significantly higher in the adults than in the children (P < 0.05). In addition, the ratio of immunoglobulin G (IgG) to IgM was higher in the children than in the adults. With an ELISA total antibody concentration of greater than or equal to 2 mu g/ml used as a measure of seroconversion, greater than or equal to 84% of the individuals from each age group responded to the serogroup C polysaccharide. However, with a greater than or equal to 4-fold-increase in bactericidal titer used, only 18% of 1-year olds, 32% of 2-year-olds, and 50 to 60% of 3-, 4-, and 5-year-olds seroconverted. The ELISA results suggest that >50% of all children retained greater than or equal to 2 mu g of total antibody per mi at 7 months postimmunization. However, the bactericidal titers suggest that < 10% of children <4 years old retained a greater than or equal to 4-fold increase at 7 months following vaccination. Of particular note, 59 of 79 sera (75%) from the 1- and 2-year-olds had high ELISA antibody concentrations (2 to 20 mu g/ml) with no associated bactericidal titer (<1:8). Discordant results between bactericidal titers and ELISA antibody concentrations were not explained by the presence of IgA blocking antibody or relative levels of IgG and IgM. The bactericidal results show age-dependent differences in the production and retention of antibody in young children immunized with serogroup C polysaccharide; these differences are not evident with the ELISA data.
引用
收藏
页码:2453 / 2459
页数:7
相关论文
共 40 条
[1]   AVIDITY OF SPECIFIC IGG ANTIBODIES ELICITED BY IMMUNIZATION AGAINST HAEMOPHILUS-INFLUENZAE TYPE-B [J].
AGBARAKWE, AE ;
GRIFFITHS, H ;
BEGG, N ;
CHAPEL, HM .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (03) :206-209
[2]   BACTERICIDAL AND OPSONIC ACTIVITY OF IGG1 AND IGG2 ANTICAPSULAR ANTIBODIES TO HAEMOPHILUS-INFLUENZAE TYPE-B [J].
AMIR, J ;
SCOTT, MG ;
NAHM, MH ;
GRANOFF, DM .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :163-171
[3]   PREVENTION OF MENINGOCOCCAL DISEASE BY GROUP-C POLYSACCHARIDE VACCINE [J].
ARTENSTEIN, MS ;
GOLD, R ;
ZIMMERLY, JG ;
WYLE, FA ;
SCHNEIDER, H ;
HARKINS, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (08) :417-+
[4]   DURATION OF ANTIBODY-RESPONSES AFTER VACCINATION WITH GROUP-C NEISSERIA-MENINGITIDIS POLYSACCHARIDE [J].
BRANDT, BL ;
ARTENSTEIN, MS .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 :S69-S72
[5]   TETRAVALENT (A, C, Y, W-135) MENINGOCOCCAL VACCINE IN CHILDREN - IMMUNOGENICITY AND SAFETY [J].
CADOZ, M ;
ARMAND, J ;
ARMINJON, F ;
GIRE, R ;
LAFAIX, C .
VACCINE, 1985, 3 (03) :340-342
[6]  
CARLONE GM, 1997, MANUAL CLIN LAB IMMU, P458
[7]   Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants [J].
Fairley, CK ;
Begg, N ;
Borrow, R ;
Fox, AJ ;
Jones, DM ;
Cartwright, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1360-1363
[8]   MULTICENTER COMPARISON OF NEISSERIA-MENINGITIDIS SEROGROUP-C ANTI-CAPSULAR POLYSACCHARIDE ANTIBODY-LEVELS MEASURED BY A STANDARDIZED ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
GHEESLING, LL ;
CARLONE, GM ;
PAIS, LB ;
HOLDER, PF ;
MASLANKA, SE ;
PLIKAYTIS, BD ;
ACHTMAN, M ;
DENSEN, P ;
FRASCH, CE ;
KAYHTY, K ;
MAYS, JP ;
NENCIONI, L ;
PEETERS, C ;
PHIPPS, DC ;
POOLMAN, JT ;
ROSENQVIST, E ;
SIBER, GR ;
THIESEN, B ;
TAI, J ;
THOMPSON, CM ;
VELLA, PP ;
WENGER, JD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (06) :1475-1482
[9]   KINETICS OF ANTIBODY-PRODUCTION TO GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDE VACCINES ADMINISTERED DURING THE 1ST 6 YEARS OF LIFE - PROSPECTS FOR ROUTINE IMMUNIZATION OF INFANTS AND CHILDREN [J].
GOLD, R ;
LEPOW, ML ;
GOLDSCHNEIDER, I ;
DRAPER, TF ;
GOTSCHLICH, EC .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (05) :690-697
[10]   HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES [J].
GOLDSCHNEIDER, I ;
GOTSCHLICH, EC ;
ARTENSTEIN, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) :1307-+